Olga Rachel Brook

Olga Rachel Brook

Auto-generated profile, based on publicly available information

Olga Rachel Brook

Department of Radiology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2021 in Nature
Verified
Journal Article
Closed access
PDF file
TDToni M. Delorey
Toni M. Delorey
CZCarly G. K. Ziegler
Carly G. K. Ziegler
GHGraham Heimberg
Graham Heimberg
RNRachelly Normand
Rachelly Normand
YYYiming Yang
Yiming Yang
ARAviv Regev
Aviv Regev

1 November 2020 in Cell
Verified
Journal Article
Closed access
MAMalika Aid
Malika Aid
KBKathleen Busman-Sahay
Kathleen Busman-Sahay
SVSamuel J. Vidal
Samuel J. Vidal
ZMZoltan Maliga
Zoltan Maliga
SBStephen Bondoc
Stephen Bondoc
DBDan H. Barouch
Dan H. Barouch

1 June 2012 in Radiology
Verified
Journal Article
Closed access
OBOlga R. Brook
Olga R. Brook
SGSofia Gourtsoyianni
Sofia Gourtsoyianni
ABAlexander Brook
Alexander Brook
AMAnand Mahadevan
Anand Mahadevan
CWCarol Wilcox
Carol Wilcox
VRVassilios Raptopoulos
Vassilios Raptopoulos
To evaluate spectral computed tomography (CT) with metal artifacts reduction software (MARS) for reduction of metal artifacts associated with gold fiducial seeds. Thirteen consecutive patients with 37 fiducial seeds implanted for radiation therapy of abdominal lesions were included in this HIPAA-compliant, institutional review board-approved prospective study. Six patients were women (46%) and seven were men (54%). The mean age was 61.1 years (median, 58 years; range, 29-78 years). Spectral imaging was used for arterial phase CT. Images were reconstructed with and without MARS in axial, coronal, and sagittal planes. Two radiologists independently reviewed reconstructions and selected the best image, graded the visibility of the tumor, and assessed the amount of artifacts in all planes. A linear-weighted κ statistic and Wilcoxon signed-rank test were used to assess interobserver variability. Histogram analysis with the Kolmogorov-Smirnov test was used for objective evaluation of artifacts reduction. Fiducial seeds were placed in pancreas (n = 5), liver (n = 7), periportal lymph nodes (n = 1), and gallbladder bed (n = 1). MARS-reconstructed images received a better grade than those with standard reconstruction in 60% and 65% of patients by the first and second radiologist, respectively. Tumor visibility was graded higher with standard versus MARS reconstruction (grade, 3.7 ± 1.0 vs 2.8 ± 1.1; P = .001). Reduction of blooming was noted on MARS-reconstructed images (P = .01). Amount of artifacts, for both any and near field, was significantly smaller on sagittal and coronal MARS-reconstructed images than on standard reconstructions (P < .001 for all comparisons). Far-field artifacts were more prominent on axial MARS-reconstructed images than on standard reconstructions (P < .01). Linear-weighted κ statistic showed moderate to perfect agreement between radiologists. CT number distribution was narrower with MARS than with standard reconstruction in 35 of 37 patients (P < .001). Spectral CT with use of MARS improved tumor visibility in the vicinity of gold fiducial seeds.

1 October 2013 in Radiology
Verified
Journal Article
Closed access
OBOlga R. Brook
Olga R. Brook
SGSofia Gourtsoyianni
Sofia Gourtsoyianni
ABAlexander Brook
Alexander Brook
BSBettina Siewert
Bettina Siewert
TKTara Kent
Tara Kent
VRVassilios Raptopoulos
Vassilios Raptopoulos

1 September 2010 in RadioGraphics
Verified
Journal Article
Closed access
OBOlga R. Brook
Olga R. Brook
AOAnna Marie O’connell
Anna Marie O’connell
ETEavan Thornton
Eavan Thornton
RERonald L. Eisenberg
Ronald L. Eisenberg
MMMishal Mendiratta-Lala
Mishal Mendiratta-Lala
JKJonathan B. Kruskal
Jonathan B. Kruskal
The Joint Commission requires development of comprehensive error detection systems that incorporate root cause analyses for all sentinel events. To prevent medical errors from occurring, there is a need for a readily available and easy-to-implement system for detecting, classifying, and managing mistakes. The wide spectrum of interrelated contributing factors makes the classification of errors difficult. Contributors to and causes of radiologic errors can be classified under latent and active failures. Latent failures include technical and system-related failures, with a radiology-specific subgroup of communication failures that includes documentation, inaccurate or incomplete information, and communication loop failures. Active failures may be ascribed to human failures (more specifically failure of execution of a task, inadequate planning, or behavior-related failures), patient-based failures, and external failures. Classification of an error should also include the impact of the error on the patient, staff, other customers, and radiology practice. Further considerations should include nonmedical impact of the error, including legal, social, and economic effects on both the patient and the system. Rather than focusing the investigation on blaming individuals for active failures, the primary effort should be to discover latent system failures that can be remedied at a departmental level. Such an error classification system will decrease the likelihood of future errors and diminish their adverse impact.

1 October 2015 in RadioGraphics
Verified
Journal Article
Closed access
OBOlga R. Brook
Olga R. Brook
JKJonathan B. Kruskal
Jonathan B. Kruskal
RERonald L. Eisenberg
Ronald L. Eisenberg
DLDavid B. Larson
David B. Larson
This article illustrates the steps and applicable tools used to perform a root cause analysis to help radiology departments learn from past adverse events and decrease the likelihood of future occurrences. Serious adverse events continue to occur in clinical practice, despite our best preventive efforts. It is essential that radiologists, both as individuals and as a part of organizations, learn from such events and make appropriate changes to decrease the likelihood that such events will recur. Root cause analysis (RCA) is a process to (a) identify factors that underlie variation in performance or that predispose an event toward undesired outcomes and (b) allow for development of effective strategies to decrease the likelihood of similar adverse events occurring in the future. An RCA process should be performed within the environment of a culture of safety, focusing on underlying system contributors and, in a confidential manner, taking into account the emotional effects on the staff involved. The Joint Commission now requires that a credible RCA be performed within 45 days for all sentinel or major adverse events, emphasizing the need for all radiologists to understand the processes with which an effectiv...